SAN ANTONIO, April 09, 2024--bioAffinity Technologies and the American Cancer Society are expanding their campaign to raise funds for lung cancer screening.
SAN ANTONIO, April 01, 2024--bioAffinity Technologies reports fourth quarter and full year 2023 financial results.
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) has closed a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered direct offering and common warrants to purchase up to 1,600,000 shares of common stock in a concurrent private placement (together with the registered direct offering) at a